1. Home
  2. EDAP vs EPIX Comparison

EDAP vs EPIX Comparison

Compare EDAP & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • EPIX
  • Stock Information
  • Founded
  • EDAP 1979
  • EPIX 2009
  • Country
  • EDAP France
  • EPIX Canada
  • Employees
  • EDAP N/A
  • EPIX N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDAP Health Care
  • EPIX Health Care
  • Exchange
  • EDAP Nasdaq
  • EPIX Nasdaq
  • Market Cap
  • EDAP 81.6M
  • EPIX 76.8M
  • IPO Year
  • EDAP 1997
  • EPIX N/A
  • Fundamental
  • Price
  • EDAP $2.58
  • EPIX $1.72
  • Analyst Decision
  • EDAP Strong Buy
  • EPIX Hold
  • Analyst Count
  • EDAP 1
  • EPIX 3
  • Target Price
  • EDAP $19.00
  • EPIX $2.00
  • AVG Volume (30 Days)
  • EDAP 42.8K
  • EPIX 253.9K
  • Earning Date
  • EDAP 03-26-2025
  • EPIX 02-11-2025
  • Dividend Yield
  • EDAP N/A
  • EPIX N/A
  • EPS Growth
  • EDAP N/A
  • EPIX N/A
  • EPS
  • EDAP N/A
  • EPIX N/A
  • Revenue
  • EDAP $70,722,730.00
  • EPIX N/A
  • Revenue This Year
  • EDAP $6.96
  • EPIX N/A
  • Revenue Next Year
  • EDAP $15.53
  • EPIX N/A
  • P/E Ratio
  • EDAP N/A
  • EPIX N/A
  • Revenue Growth
  • EDAP 12.17
  • EPIX N/A
  • 52 Week Low
  • EDAP $2.00
  • EPIX $1.40
  • 52 Week High
  • EDAP $8.50
  • EPIX $9.92
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 54.13
  • EPIX 47.93
  • Support Level
  • EDAP $2.46
  • EPIX $1.69
  • Resistance Level
  • EDAP $2.69
  • EPIX $1.83
  • Average True Range (ATR)
  • EDAP 0.14
  • EPIX 0.07
  • MACD
  • EDAP 0.01
  • EPIX 0.01
  • Stochastic Oscillator
  • EDAP 48.39
  • EPIX 57.69

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Share on Social Networks: